International Drug Regulatory Mechanisms by Wertheimer, Albert I;

Rövid leírás:

International Drug Regulatory Mechanisms explores the environment, organization, structure, functioning, and finance of health systems and pharmaceutical markets in 19 countries. Local experts describe each country's experiences with and lessons learned from the regulation of pharmaceutical products. This book will help government officials, pharmacy educators, and pharmaceutical industry leaders from around the globe identify and utilize successful methods for controlling pharmaceutical drug prices and utilization.

Több

Hosszú leírás:

Learn how international governments have committed themselves to improving access to quality health care!

International Drug Regulatory Mechanisms explores the environment, organization, structure, functioning, and finance of health systems and pharmaceutical markets in 19 countries. Local experts describe each country’s experiences with and lessons learned from the regulation of pharmaceutical products. This book will help government officials, pharmacy educators, and pharmaceutical industry leaders from around the globe identify and develop successful methods for controlling pharmaceutical drug prices and utilization.

In International Drug Regulatory Mechanisms, you will learn about the health care system of each country and each government’s measures to control drug costs. This text shows you what government interventions are feasible as well as effective, and the impact of these measures on consumers, government agencies, and the pharmaceutical companies and distributors. Drug policies, reimbursement concepts, and health insurance companies are all examined to give you a better working knowledge of the methodology and guidelines involving drug control in nations such as:

• Iceland
• Canada
• Israel
• Malaysia
• Argentina
• Taiwan
• Mexico
• Italy

International Drug Regulatory Mechanisms is an extensive text that shows how pharmaceuticals are regulated throughout the world. This book examines how—despite similar goals—price controls, utilization controls, record keeping, and quality requirements differ greatly between countries. Using numerous graphs, tables, and figures, this one-of-a-kind resouce provides you with new insight into which strategies are superior and how to implement these strategies in your own country.

Learn how international governments have committed themselves to improving access to quality health care!

International Drug Regulatory Mechanisms explores the environment, organization, structure, functioning, and finance of health systems and pharmaceutical markets in 19 countries. Local experts describe each country’s experiences with and lessons learned from the regulation of pharmaceutical products. This book will help government officials, pharmacy educators, and pharmaceutical industry leaders from around the globe identify and develop successful methods for controlling pharmaceutical drug prices and utilization.

In International Drug Regulatory Mechanisms, you will learn about the health care system of each country and each government’s measures to control drug costs. This text shows you what government interventions are feasible as well as effective, and the impact of these measures on consumers, government agencies, and the pharmaceutical companies and distributors. Drug policies, reimbursement concepts, and health insurance companies are all examined to give you a better working knowledge of the methodology and guidelines involving drug control in nations such as:

• Iceland
• Canada
• Israel
• Malaysia
• Argentina
• Taiwan
• Mexico
• Italy

International Drug Regulatory Mechanisms is an extensive text that shows how pharmaceuticals are regulated throughout the world. This book examines how—despite similar goals—price controls, utilization controls, record keeping, and quality requirements differ greatly between countries. Using numerous graphs, tables, and figures, this one-of-a-kind resouce provides you with new insight into which strategies are superior and how to implement these strategies in your own country.

Több

Tartalomjegyzék:

• Foreword (Greg Perkins)
  
• Interventions to Curb Rising Pharmaceutical Costs in Iceland (Anna Birna Almarsdóttir, Almar Grímsson, and Ingunn Björnsdóttir)
  
• Canadian Public Policies and Practices Related to Drug Prices, Utilization and Expenditures (Ingrid Sketris, Susan Bowles, and Richard Manuel)
  
• Drug Policy in the Czech Republic (Lenka Praznovcova, Josef Suchopar, and Albert I. Wertheimer)
  
• Drug Policies and Pricing Mechanism: The Malaysian Perspective (Mohamed Izham Mohamed Ibrahim and Salmah Bahri)
  
• Drug Pricing in South Africa—Policy and Praxis (Andy L. Gray and Thulani Matsebula)
  
• Drug Price Control in India—An Overview (Mansi B. Shah and Amit S. Patel)
  
• Pharmaceutical Benefit Scheme and Cost Containment in Taiwan’s National Health Insurance (Weng-Foung Huang and Hung-Chi Chiang)
  
• Rx Price Control Methods in Mexico (Jaime Kravzov-Jinich, Marina Altagracia-Martínez, Martha Elena Yamasaki-López, Hector Salgado-Schoelly, and Claudia Cardona-Carlín)
  
• Financing Pharmaceutical Care in the Dutch Health System (Han de Gier)
  
• Drug Pricing Policy in Hungary (Zoltán Vincze, Romána Zelkó, and Ágnes Mészáros)
  
• Germany’s Attempts to Control Drug Prices and Expenditures: Success or Failure? (Eva Susanne Dietrich)
  
• Regulating the Prices and Costs of Medicines in the United Kingdom (David Taylor)
  
• The Controls of Prices of Medicines in Israel (Avi Moshenson and Howard Rice)
  
• Pharmaceutical Services in Slovenia (Jurij Fürst)
  
• Pricing and Reimbursement of Medicinal Products in Denmark (Karen Kolenda and Henrik Vestergaard)
  
• Drug Prices in Argentina (Marcelo J. Vernengo and Ricardo Bolaños)
  
• Drug Pricing and Reimbursement System in Turkey (Selen Yegenoglu)
  
• Medication Expenditure and Utilization in Morocco (Batoul Senhaji)
  
• Pharmaceutical Expenditure: Aspects of Cost Containment in Italy (Luciana Scalone, Simon de Portu, Paola Minghetti, and Lorenzo G. Mantovani)
  
• Organization of Health Care Systems and Financing of Pharmaceuticals in Norway, Including Cost Containments (Geir Bredesen)
  
• Index
  
• Reference Notes Included
  

Több